Current treatment options for systemic lupus erythematosus (SLE ... low-dose oral for mild disease; moderate to high-dose oral for more severe disease; intravenous for very severe or life ...

Scientists in London have found that even mild cases of the virus could trigger long-lasting effects on the brain, possibly increasing the risk of the brain-eating disease Alzheimer's ...

ASA 1: Clinically healthy. ASA 2: Mild systemic disease without significant functional limitation. Some ASA 3: Severe systemic disease with significant functional limitation – clinical discretion ...

A new study has found that Covid-19 could affect brain proteins linked to Alzheimer's disease, the most common form of ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

MANY people who have had Covid-19 will be familiar with the ‘brain fog’ that lingers in the weeks or months after getting ...

Symptom control Use of rapidly acting agents tailored to the nature and severity of the manifestation Glucocorticoids: topical for mild cutaneous lupus; low-dose oral for mild disease; moderate to ...